Key result
Cardiac biomarkers draw increasing study for cardiovascular risk assessment in athletes.
Why the study?
Physical activity can trigger major adverse cardiovascular events in athletes, motivating the evaluation of cardiac biomarkers to more accurately estimate cardiovascular risk in sports cardiology.
What is the potential use of cardiac biomarkers (troponins, myoglobin, CK-MB, NT-proBNP, D-Dimers) in assessing cardiovascular risk in athletes?
What is the potential use of cardiac biomarkers (troponins, myoglobin, CK-MB, NT-proBNP, D-Dimers) in assessing cardiovascular risk in athletes?
This review summarizes published data on the potential utility of cardiac biomarkers for cardiovascular risk assessment in athletes.
Cardiac biomarkers merit cautious interpretation in athletes; leaves open standardized risk assessment pending prospective validation.
Sustained physical activity induces morphological and functional changes in the cardiovascular system. While mostly physiological, they can also become a trigger for major adverse cardiovascular events, the most severe of which are sudden cardiac arrest and sudden cardiac death. Therefore, any novel method which can help more accurately estimate the cardiovascular risk should be considered for further studying and future implementation in the standard protocols. The study of biomarkers is gaining more and more ground as they have already established their utility in diagnosing ischemic cardiac disease or in evaluating cardiac dysfunction in patients with heart failure. Nowadays, they are being implemented in the screening of apparently healthy individuals for the assessment of the cardiovascular risk. The aim of this paper is to gather published data regarding the measurements of cardiac biomarkers in athletes, i.e., troponins, myoglobin, CK-MB, NT-proBNP, and D-Dimers, and their potential use in the field of sports cardiology.
No takes yet. Share an insight, caveat, or question.
Costache et al. (2022) conducted a review in Cardiovascular risk in athletes. Cardiac biomarkers (troponins, myoglobin, CK-MB, NT-proBNP, D-Dimers) was evaluated. The measurement of cardiac biomarkers, including troponins, myoglobin, CK-MB, NT-proBNP, and D-Dimers, is being increasingly studied for cardiovascular risk assessment in athletes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: